229 related articles for article (PubMed ID: 2591151)
1. Response to desmopressin in type IID von Willebrand's disease.
Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
[TBL] [Abstract][Full Text] [Related]
2. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
4. DDAVP in type IIa von Willebrand's disease.
Gralnick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
Blood; 1986 Feb; 67(2):465-8. PubMed ID: 3080040
[TBL] [Abstract][Full Text] [Related]
5. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers.
Mannucci PM; Lombardi R; Castaman G; Dent JA; Lattuada A; Rodeghiero F; Zimmerman TS
Blood; 1988 Jan; 71(1):65-70. PubMed ID: 3257148
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.
Casonato A; Pontara E; Dannhaeuser D; Bertomoro A; Sartori MT; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):959-64. PubMed ID: 7893933
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J
Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
Holmberg L; Berntorp E; Donnér M; Nilsson IM
Blood; 1986 Sep; 68(3):668-72. PubMed ID: 3488775
[TBL] [Abstract][Full Text] [Related]
10. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
Rodeghiero F; Castaman G; Di Bona E; Ruggeri M; Lombardi R; Mannucci PM
Eur J Haematol; 1988 Feb; 40(2):163-7. PubMed ID: 3126081
[TBL] [Abstract][Full Text] [Related]
11. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
13. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity.
Federici AB; Mannucci PM; Lombardi R; Lattuada A; Colibretti ML; Dent JA; Zimmerman TS
Am J Hematol; 1989 Dec; 32(4):287-93. PubMed ID: 2510503
[TBL] [Abstract][Full Text] [Related]
14. Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy.
López-Fernández MF; López-Berges C; Martín R; Nieto J; del Rio F; López-Borrasca A; Batlle J
Scand J Haematol; 1986 Mar; 36(3):302-8. PubMed ID: 3486452
[TBL] [Abstract][Full Text] [Related]
15. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
[TBL] [Abstract][Full Text] [Related]
16. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.
Casonato A; Sartori MT; Pontara E; Zucchetto A; Dannhäuser D; Patrassi G; Girolami A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):149-53. PubMed ID: 1606286
[TBL] [Abstract][Full Text] [Related]
17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
20. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.
Casonato A; Pontara E; Sartorello F; Cattini MG; Sartori MT; Padrini R; Girolami A
Blood; 2002 Jan; 99(1):180-4. PubMed ID: 11756169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
